Megan Herink

5PUBLICATIONS
4CO-AUTHORS
Correctional theory, offender treatment and rehabilitationEpidemiological methodsClinical pharmacy and pharmacy practicePharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 28, 2024
Harm Reduction in Peer-Assisted Telemedicine for Hepatitis C: Secondary Outcomes of a Randomized Controlled Trial.

Hunter Spencer, Devin Gregoire, Gillian Leichtling

|May 27, 2023
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.

Megan C Herink, Andrew Seaman, Gillian Leichtling

|Oct 26, 2022
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation.

Megan C Herink, Kirbee Johnston, Kristin Breninger

|Aug 24, 2019
Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs).

Megan C Herink, Yan F Zhuo, Craig D Williams

|Jul 26, 2018
FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals.

Megan C Herink, Adriane N Irwin, Gregory M Zumach

Pageof 1

Frequent Collaborators

2 joint publications

Adriane N Irwin

1 joint publications

Hunter Spencer

1 joint publications

Gillian Leichtling

1 joint publications

P Todd Korthuis